Google Ads vs Facebook Ads for Peptide Clinics: Which Works Better

Google Ads and Facebook Ads are the two dominant platforms for peptide therapy patient acquisition, and every clinic owner asks the same question: which one should I use? The honest answer is that they serve fundamentally different purposes, attract patients at different stages of their decision-making process, and perform best when used together. But understanding when and why to use each platform will save you money and help you build a patient pipeline that delivers consistent results month after month.

Google Ads captures high-intent patients. When someone types 'BPC-157 therapy near me' or 'peptide clinic Houston' into Google, they are actively looking for treatment. They have already decided they want peptide therapy. They just need to find the right provider. This is the highest-quality traffic you can buy in digital advertising. These patients convert at significantly higher rates than any other source because their intent is already established. Google Ads is your best channel for patients who are ready to book now. The downside is cost. High-intent keywords in the peptide therapy space can run $15 to $40 per click depending on your market, and competition for top ad positions is increasing as more clinics enter the space.

Facebook Ads works differently. Nobody opens Facebook or Instagram thinking 'I need to find a peptide therapy clinic today.' Instead, Facebook Ads targets people based on interests, demographics, and behaviors that indicate they might be candidates for peptide therapy. You can reach people interested in anti-aging, fitness recovery, biohacking, weight management, hormone optimization, and related topics. Facebook Ads is an awareness and education tool. It introduces your clinic to people who may not know peptide therapy exists, or who have heard of it but have not yet taken the step to search for a provider. The cost per click is lower than Google ($2 to $8 typically), but the conversion rate is also lower because you are reaching people earlier in their decision journey.

The patient journey looks different on each platform, and this matters for your campaign strategy. A Google Ads patient might see your ad, click through to your landing page, and submit a consultation request in the same session. The path from click to lead can happen in 60 seconds. A Facebook Ads patient might see your ad, visit your website, leave without taking action, see a retargeting ad three days later, read a blog post on your site, and finally submit a form a week after their first interaction. Facebook requires more touchpoints and more patience, but it also reaches patients that Google never would, people who did not know they were interested until your ad put the idea in front of them.

For most peptide therapy clinics, the ideal approach is running both platforms simultaneously with different objectives. Google Ads handles the bottom of the funnel, capturing patients who are actively searching and ready to book. Facebook Ads handles the top and middle of the funnel, building awareness, educating potential patients, and feeding your Google campaigns by increasing the number of people who eventually search for peptide therapy. Clinics that run both platforms together consistently generate 30 to 50 percent more total leads than those running either platform alone, because the two channels reinforce each other. A patient sees your Facebook ad on Monday, thinks about it for a few days, then searches Google on Thursday and clicks your search ad. Without the Facebook exposure, that Google search might never have happened.

The budget split between platforms depends on your market and goals. A common starting allocation is 60 to 70 percent of budget on Google Ads and 30 to 40 percent on Facebook Ads. Google gets the larger share because of the higher conversion rates and immediate return. Facebook gets enough budget to build awareness and fill the top of your funnel. As you gather data and understand which platform is producing better results in your specific market, you adjust the split accordingly. Some clinics in competitive metros find that Facebook Ads actually delivers lower cost per patient because Google Ads click costs are so high in their area.

Here is the part that matters most: running these campaigns properly is a full-time job that requires specialized knowledge. Google's healthcare advertising policies require verification and careful compliance. Facebook's ad platform changes its targeting options and policies constantly. Landing page optimization, conversion tracking, A/B testing, bid management, audience segmentation. Each of these is a discipline that takes months or years to master. A clinic owner trying to manage Google and Facebook campaigns while seeing patients and running a business is going to get mediocre results from both platforms. This is not a criticism. It is a reality of how complex digital advertising has become. You can read about our full process at /how-it-works to understand what professional campaign management looks like.

The smartest move for most peptide therapy clinics is to let a specialist handle both platforms while you focus on patient care. At PeptideLeads, we run Google Ads and Facebook Ads campaigns built specifically for peptide therapy clinics, and we absorb all the ad spend and management costs ourselves. You pay $50 per qualified lead delivered, regardless of which platform generated it. You do not need to choose between Google and Facebook, manage budgets, worry about compliance, or spend hours in ad dashboards. You get patients. That is the entire value proposition. Whether those patients found you through a Google search or a Facebook ad is our problem to solve, not yours.